Corrigendum to “Controllable release of nitric oxide and doxorubicin from engineered nanospheres for synergistic tumor therapy” [Acta Biomaterialia 57, 2017, 498-510]
Lianjiang Tan , Ran Huang , Xiaoqiang Li , Shuiping Liu , Yu-Mei Shen
{"title":"Corrigendum to “Controllable release of nitric oxide and doxorubicin from engineered nanospheres for synergistic tumor therapy” [Acta Biomaterialia 57, 2017, 498-510]","authors":"Lianjiang Tan , Ran Huang , Xiaoqiang Li , Shuiping Liu , Yu-Mei Shen","doi":"10.1016/j.actbio.2025.01.063","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"196 ","pages":"Pages 537-539"},"PeriodicalIF":9.4000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Biomaterialia","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1742706125000832","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
期刊介绍:
Acta Biomaterialia is a monthly peer-reviewed scientific journal published by Elsevier. The journal was established in January 2005. The editor-in-chief is W.R. Wagner (University of Pittsburgh). The journal covers research in biomaterials science, including the interrelationship of biomaterial structure and function from macroscale to nanoscale. Topical coverage includes biomedical and biocompatible materials.